Award
National Institute of Allergy and Infectious Diseases 5R01AI179666-04
Determining the effects of broadly neutralizing antibodies at antiretroviral therapy initiation
Recipient
Not specified
Award Amount
$812,740.00
Ceiling
$812,740.00
Awarded
July 22, 2026
Identifier
5R01AI179666-04
Research project awarded by NIAID to study the effects of broadly neutralizing antibodies in HIV treatment using a nonhuman primate model, aiming to understand virus reservoir reduction and immune response enhancement.
Description
This project involves research on broadly neutralizing antibodies (bnAbs) in HIV treatment, utilizing a novel nonhuman primate model to assess the effects of bnAbs at antiretroviral therapy initiation and re-initiation. The study aims to elucidate mechanisms of virus reservoir reduction and immune response enhancement, with potential implications for HIV cure strategies.